Ted Butterfield
Foot & Ankle Surgery · Cordova, TNNPI 1396003638
Payments from drug & device makers
Across 45 payments — averaging $36.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gentleman Orthopedic Solutions$775
- Melinta Therapeutics, LLC$214
- Amgen$135
- Bioventus LLC$115
- Smith+Nephew$64
- KCI USA, Inc.$59
- plus $296 from 15 others
What the payments were for
- Food & beverage$88453%
- Education$77547%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gentleman Orthopedic Solutions | 1 | $775 |
| Melinta Therapeutics, LLC | 12 | $214 |
| Amgen | 7 | $135 |
| Bioventus LLC | 2 | $115 |
| Smith+Nephew | 4 | $64 |
| KCI USA, Inc. | 1 | $59 |
| Organogenesis Inc. | 3 | $38 |
| Acera Surgical, Inc. | 2 | $28 |
| Averitas Pharma Inc. | 1 | $26 |
| Goode Surgical Inc | 1 | $26 |
| Alfasigma USA, Inc. | 1 | $24 |
| Nevro Corp. | 1 | $21 |
| Osiris Therapeutics Inc. | 1 | $20 |
| AbbVie | 1 | $18 |
| Cumberland Pharmaceuticals, Inc. | 1 | $17 |
| Solventum Corporation | 1 | $17 |
| Orthofix Medical, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
| Boston Scientific | 1 | $12 |
| Stimwave Technologies Incorporated | 1 | $11 |
How this compares
$1,659 in reported general payments places this provider in the 30th percentile of 145 foot & ankle surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 19 | $492 |
| Gabapentin | 19 | $423 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $335 |
| Terbinafine Hcl | 12 | $235 |
| Clindamycin Hcl | 19 | $150 |
| Methylprednisolone | 18 | $139 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $138 |
| Naproxen | 15 | $132 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $130 |
| Triamcinolone Acetonide | 12 | $128 |
| Meloxicam | 23 | $92 |
| Cephalexin | 14 | $75 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Cordova
- Chad WebsterCordova$185K
- Christian SmithCordova$153K
- Kaihua WangCordova$12K
- Nathan ColemanCordova$8K
- Frank OgnibeneMemphis$353K
- Garnett MurphyGermantown$225K
- Sebastien DemoinyMorristown$210K
- Robert ThompsonMurfreesboro$205K
- Bhekumuzi KhumaloUnion City$201K
- Walter ButlerMemphis$191K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.